UPDATES
Executive Board 134
Today the Executive Board of the World Health Organisation (WHO) discussed the issue of substandard/spurious/falsely labelled/falsified/counterfeit (SSFFC) medical products. Counterfeit medicines threaten health systems worldwide. Many countries stressed the need for enhanced regulatory capacity to be achieved, in particular, by fostering regulatory convergence. During her opening address on Monday 20 January, Director-General of WHO, Dr. Margaret Chan, made reference to the regulatory challenge posed by counterfeit medicines stating: “The need for stronger systems for regulatory Read more…








